Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NovaCross CTO Microcatheter

K-Number: K193322 · 2020-04-02

Decision Date2020-04-02
Product CodeDQY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

NovaCross CTO Microcatheter is a medical device manufactured by Nitiloop , Ltd.. It received FDA 510(k) clearance on 2020-04-02 under approval number K193322. The device is classified under product code DQY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NovaCross CTO Microcatheter?

NovaCross CTO Microcatheter is a medical device that received FDA 510(k) clearance on 2020-04-02. It is manufactured by Nitiloop , Ltd.. The 510(k) number is K193322.

When was NovaCross CTO Microcatheter approved by the FDA?

NovaCross CTO Microcatheter received FDA 510(k) clearance on 2020-04-02, under approval number K193322.

What company makes NovaCross CTO Microcatheter?

NovaCross CTO Microcatheter is manufactured by Nitiloop , Ltd..

What is the FDA product code for NovaCross CTO Microcatheter?

The FDA product code for NovaCross CTO Microcatheter is DQY.

Other Devices by Nitiloop , Ltd.

Related Devices (Code: DQY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.